FORTAZ is a Intramuscular; Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Teligent Pharma, Inc.. The primary component is Ceftazidime.
Product ID | 52565-107_0f74328a-b2ef-46ab-8bf4-ebceec1cc896 |
NDC | 52565-107 |
Product Type | Human Prescription Drug |
Proprietary Name | FORTAZ |
Generic Name | Ceftazidime |
Dosage Form | Injection, Powder, For Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 2012-12-14 |
Marketing Category | NDA / NDA |
Application Number | NDA050578 |
Labeler Name | Teligent Pharma, Inc. |
Substance Name | CEFTAZIDIME |
Active Ingredient Strength | 170 mg/mL |
Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-10-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050578 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-10-19 |
Marketing Category | NDA |
Application Number | NDA050578 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-10-19 |
Marketing End Date | 2019-09-12 |
Ingredient | Strength |
---|---|
CEFTAZIDIME | 170 mg/mL |
SPL SET ID: | 78982c98-7866-49f1-989f-a289c4242358 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
52565-106 | FORTAZ | FORTAZ |
52565-111 | FORTAZ | FORTAZ |
52565-112 | FORTAZ | FORTAZ |
52565-113 | FORTAZ | FORTAZ |
52565-109 | FORTAZ | FORTAZ |
52565-107 | FORTAZ | FORTAZ |
52565-105 | FORTAZ | FORTAZ |
52565-110 | FORTAZ | FORTAZ |
0781-3177 | Ceftazidime | Ceftazidime |
0781-3178 | Ceftazidime | Ceftazidime |
0781-3179 | Ceftazidime | Ceftazidime |
25021-127 | Ceftazidime | ceftazidime |
0264-3143 | Ceftazidime and Dextrose | CEFTAZIDIME |
0264-3145 | Ceftazidime and Dextrose | CEFTAZIDIME |
0409-5082 | TAZICEF | CEFTAZIDIME |
0409-5084 | TAZICEF | CEFTAZIDIME |
0409-5086 | TAZICEF | CEFTAZIDIME |
0409-5092 | TAZICEF | CEFTAZIDIME |
0409-5093 | TAZICEF | CEFTAZIDIME |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FORTAZ 73376990 1286762 Live/Registered |
Glaxo Group Limited 1982-07-28 |